EAGLE CRAIG 4

What Happened

• Craig Eagle, Chief Medical Officer of Guardant Health, had restricted stock units (RSUs) vest on March 15, 2026. A total of 15,114 shares were converted/exercised from derivative awards (13,712 + 1,402) at $0.00 per share (reflecting vesting, not a cash purchase).
• To satisfy tax withholding, the company retained (disposed) 7,661 of those shares at $85.49 per share, resulting in proceeds of $654,939. The net shares delivered to Eagle were 7,453 (15,114 vested minus 7,661 withheld).

Key Details

• Transaction date: March 15, 2026 (Form 4 filed March 17, 2026).
• Conversion/vesting: 13,712 and 1,402 shares (total 15,114) reported as exercised/converted (transaction code M) at $0.00.
• Tax withholding: 7,661 shares withheld/disposed (transaction code F) at $85.49; total reported proceeds $654,939.
• Net shares issued to insider: 7,453 shares.
• Shares owned after transaction: Not disclosed in the provided filing details.
• Footnotes of note:
  • F1: Company retained shares only to meet the award-holder’s tax withholding obligation; not in excess of the tax liability.
  • F2: The 1,402-share component is from a performance-based RSU grant (June 7, 2023) whose second tranche vested on March 15, 2026.
  • F4: The 13,712-share component relates to a time-based RSU grant (June 9, 2023) with scheduled vesting over three years.
• Filing timeliness: Form filed two days after the transaction date; no late filing flag indicated in the provided data.

Context

• These entries reflect RSU vesting and company share-withholding for taxes (a common, routine administrative step), not an open-market sale or purchase by the insider. Acquisitions at $0.00 indicate receipt of vested awards rather than a cash purchase. Withholding to cover taxes should not be interpreted as a directional investment signal.